1-2 of 2
Srimoyee Ghosh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo

Srimoyee Ghosh, Geeta Sharma, Jon Travers, Sujatha Kumar, Justin Choi, H. Toni Jun, Marilyn Kehry, Sridhar Ramaswamy, David Jenkins
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 632–641.
https://doi.org/10.1158/1535-7163.MCT-18-0836
Published: 01 March 2019
View article titled, TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <em>In Vitro</em> and <em>In Vivo</em>
Open the PDF for TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <em>In Vitro</em> and <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Abstract A201: Discovery of TSR-033, a novel, potent anti-human LAG-3 therapeutic antibody

Srimoyee Ghosh, Haley Laken, Jon Travers, Sujatha Kamar, H. Toni Jun, Marilyn R. Kehry, David Jenkins
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A201.
https://doi.org/10.1158/1535-7163.TARG-17-A201
Published: 01 January 2018
View article titled, Abstract A201: Discovery of TSR-033, a novel, potent anti-human LAG-3 therapeutic antibody